NCT02280954View on ClinicalTrials.gov

Indocyanine Green for Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
Solid TumorNeoplasms
Interventions
DRUG

Indocyanine Green (ICG)

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02280954 - Indocyanine Green for Solid Tumors | Biotech Hunter | Biotech Hunter